Research & Insights
September 25, 2023
Lazard Global Biopharmaceutical Leaders Study 2023
The biopharma industry continues to be challenged by increased equity market volatility, following a period of unprecedented optimism and interest from generalists during the COVID-19 pandemic.
Domestic Debt Restructuring: An Exercise in Laser Surgery
Lazard Sovereign Advisory explores the use cases, benefits and pitfalls of Domestic Debt Restructuring

Lazard Interim Secondary Market Report 2023
Lazard Interim Secondary Market Report 2023
